Monash IVF Group (ASX:MVF) now expects fiscal 2025 underlying group net profit after tax to be about AU$27.5 million, compared with its previous guidance of between AU$30 million and AU$31 million, according to a Tuesday Australian bourse filing.
The company said its revised guidance reflects its assessment of softer market and operating conditions that worsened in April across all of its geographic markets.
The company added that its new Australian vitro fertilization (IVF) patient resgistration, returning IVF patients for stimulated cycles, and other indicators are currently consistent with the months before it dsiclosed the Brisbane incident, where an embryo was mistakenly implanted into the wrong patient at its Brisbane clinic, resulting in the birth of a child.
The company will disclose its fiscal 2025 results on Aug. 22.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。